Andrea Murray is developing light-based imaging techniques like nailfold capillaroscopy, laser Doppler imaging, and multispectral imaging to better measure and monitor scleroderma disease severity, progression, and treatment response. These non-invasive techniques could provide improved disease management. Specifically, her research has advanced nailfold capillaroscopy by automating capillary measurement, shown laser Doppler imaging can measure blood flow changes in digital ulcers, and a pilot study found multispectral imaging can differentiate oxygenation changes between scleroderma patients and healthy controls. The overall aim is to validate these techniques to better target and monitor scleroderma treatments.